SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) October 7, 2004

 

Inverness Medical Innovations, Inc.
(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

001-16789

 

04-3565120

(State or other jurisdiction of
incorporation)

 

(Commission file number)

 

(IRS Employer Identification
No.)

 

51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (781) 647-3900

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

ITEM 8.01    OTHER EVENTS

 

A copy of our press release entitled “Inverness Medical Innovations Updates Acon Laboratories Litigation,” dated October 7, 2004 is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS

 

c)

Exhibits. The following exhibits are filed with this document.

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press Release dated October 7, 2004, entitled “Inverness Medical Innovations Updates Acon Laboratories Litigation “

 

2

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

INVERNESS MEDICAL INNOVATIONS, INC.

 

 

 

BY:

/s/ Jay McNamara

 

 

Jay McNamara

 

 

Associate General Counsel & Assistant
Secretary

 

 

 

 Dated: October 7, 2004

 

 

 

3

 

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press Release dated October 7, 2004 entitled “Inverness Medical Innovations Updates Acon Laboratories Litigation”

 

4